Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|March 11, 2015
trans-3,4-Disubstituted pyrrolidines as inhibitors of the human aspartyl protease renin. Part II: prime site exploration using an oxygen linkerHolger Sellner, Sylvain Cottens, Frédéric Cumin, et al.Acta Crystallographica. Section D, Biological Crystallography|December 4, 2003
Crystallization and preliminary X-ray diffraction data of Mycobacterium tuberculosis FbpC1 (Rv3803c)Rosalind A Wilson, Sonia Rai, Willian N Maughan, et al.The Journal of Biological Chemistry|March 7, 2014
Small molecule-facilitated degradation of ANO1 protein: a new targeting approach for anticancer therapeuticsAnke Bill, Michelle Lynn Hall, Jason Borawski, et al.Journal of Medicinal Chemistry|August 5, 2005
Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomerRainer Albert, Klaus Hinterding, Volker Brinkmann, et al.Journal of the American Chemical Society|April 11, 2013
A (3 + 3)-dimensional "hypercubic" oxide-ionic conductor: type II Bi2O3-Nb2O5Chris D Ling, Siegbert Schmid, Peter E R Blanchard, et al.Bioorganic & Medicinal Chemistry Letters|November 3, 2015
Discovery of 1H-pyrazolo[3,4-b]pyridines as potent dual orexin receptor antagonists (DORAs)Dirk Behnke, Simona Cotesta, Samuel Hintermann, et al.Journal of Medicinal Chemistry|February 22, 2013
The discovery of novel potent trans-3,4-disubstituted pyrrolidine inhibitors of the human aspartic protease renin from in silico three-dimensional (3D) pharmacophore searchesEdwige Lorthiois, Werner Breitenstein, Frederic Cumin, et al.Bioorganic & Medicinal Chemistry Letters|February 21, 2017
Discovery of 2-oxopiperazine dengue inhibitors by scaffold morphing of a phenotypic high-throughput screening hitCyrille S Kounde, Hui-Quan Yeo, Qing-Yin Wang, et al.Journal of Medicinal Chemistry|April 2, 2004
Orally bioavailable competitive CCR5 antagonistsGebhard Thoma, François Nuninger, Marc Schaefer, et al.Journal of Medicinal Chemistry|August 29, 2020
Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral ExposureJuraj Velcicky, Rainer Wilcken, Simona Cotesta, et al.Pageof 6